-
公开(公告)号：US08999499B2
公开(公告)日：2015-04-07
申请号：US12857982
申请日：2010-08-17
Applicant: Heon Jung Shin , Jae Seog Ju , Min Ju Kim
Inventor： Heon Jung Shin , Jae Seog Ju , Min Ju Kim
CPC classification number: C08J5/18 , B29C55/12 , C08J2367/02 , C08K3/013 , C08L25/06 , C08L67/02 , Y10T428/249978 , Y10T428/249979 , Y10T428/249986 , C08L2666/02
Abstract: A white porous polyester film of the present invention comprising a polyester-based monopolymer/copolymer blend, a crystalline polymer resin which is not miscible with a polyester and has a heat deformation temperature of 90° C. or higher, inorganic particles, a whitening agent, and a stabilizing agent has improved optical properties, and thus is useful as a film for use in printing, labeling, electronics, and display applications.
Abstract translation: 本发明的白色多孔聚酯膜包含聚酯类单体/共聚物共混物，与聚酯不混溶并且热变形温度为90℃以上的结晶聚合物树脂，无机颗粒，增白剂 并且稳定剂具有改善的光学性能，因此可用作用于印刷，标记，电子和显示应用的膜。
-
公开(公告)号：US20140213642A1
公开(公告)日：2014-07-31
申请号：US14123793
申请日：2012-06-14
Applicant: Min Ju Kim , Suk Ho Lee , Soongyu Choi
Inventor： Min Ju Kim , Suk Ho Lee , Soongyu Choi
IPC: C07D491/056
CPC classification number: C07D491/056 , C07D493/08
Abstract: Disclosed is a novel C-aryl ansa compound having an inhibitory activity against sodium-dependent glucose cotransporter 2 (SGLT2) being present in the intestine and kidney, and a pharmaceutical composition comprising the same as an active ingredient, which is useful for preventing or treating metabolic disorders, particularly diabetes. Also provided are a method for preparing the compound, and a method for preventing or treating metabolic disorders, particularly diabetes, by using the compound.
Abstract translation: 公开了一种对肠和肾中存在的钠依赖性葡萄糖协同转运蛋白2（SGLT2）具有抑制活性的新型C-芳基硫化合物，以及包含其作为活性成分的药物组合物，其可用于预防或治疗 代谢紊乱，特别是糖尿病。 还提供了制备该化合物的方法，以及通过使用该化合物来预防或治疗代谢紊乱，特别是糖尿病的方法。
-
3.发明授权Thiazole derivatives as SGLT2 inhibitors and pharmaceutical composition comprising same 有权作为SGLT2抑制剂的噻唑衍生物和包含其的药物组合物
公开(公告)号：US08586550B2
公开(公告)日：2013-11-19
申请号：US13704081
申请日：2011-06-10
Applicant: Jinhwa Lee , Jeongmin Kim , Suk Ho Lee , Junwon Lee , Kwang-Seop Song , Eun-Jung Park , Min Ju Kim , Hee Jeong Seo , Sung-Han Lee , Eun Jung Son , Jong Yup Kim , Suk Youn Kang , Younggyu Kong
Inventor： Jinhwa Lee , Jeongmin Kim , Suk Ho Lee , Junwon Lee , Kwang-Seop Song , Eun-Jung Park , Min Ju Kim , Hee Jeong Seo , Sung-Han Lee , Eun Jung Son , Jong Yup Kim , Suk Youn Kang , Younggyu Kong
IPC: A61K31/70 , A61K31/425 , C07H5/04 , C07H5/06 , C07D277/60
CPC classification number: C07H7/04 , C07D309/10 , C07D417/10 , C07D417/14 , C07D493/10 , C07H17/02
Abstract: The present invention relates to a novel compound with thiazole ring having an inhibitory activity against sodium-dependent glucose cotransporter 2 (SGLT2) being present in the intestine and kidney, and a pharmaceutical composition comprising the same as an active ingredient, which is useful for preventing or treating metabolic disorders, particularly diabetes.
Abstract translation: 本发明涉及一种具有对存在于肠和肾中的钠依赖性葡萄糖协同转运蛋白2（SGLT2）具有抑制活性的噻唑环的新型化合物，以及包含其作为活性成分的药物组合物，其可用于预防 或治疗代谢紊乱，特别是糖尿病。
-
4.发明授权C-aryl glucoside SGLT2 inhibitors and pharmaceutical compositions comprising same 有权C-芳基葡糖苷SGLT2抑制剂和包含其的药物组合物
公开(公告)号：US08541380B2
公开(公告)日：2013-09-24
申请号：US13379301
申请日：2010-06-18
Applicant: Jinhwa Lee , Suk Ho Lee , Hee Jeong Seo , Min Ju Kim , Suk Youn Kang , Jeongmin Kim , Sung-Han Lee , Myung Eun Jung , Eun Jung Son , Kwang-Seop Song , Mi-Soon Kim
Inventor： Jinhwa Lee , Suk Ho Lee , Hee Jeong Seo , Min Ju Kim , Suk Youn Kang , Jeongmin Kim , Sung-Han Lee , Myung Eun Jung , Eun Jung Son , Kwang-Seop Song , Mi-Soon Kim
CPC classification number: C07D417/14 , C07D405/10 , C07D405/14 , C07D409/14 , C07D413/14 , C07D417/10
Abstract: A novel C-aryl glucoside compound, or a pharmaceutically acceptable salt or a prodrug thereof having an inhibitory activity against sodium-dependent glucose cotransporter 2 (SGLT2) being present in the intestine and kidney; and a pharmaceutical composition comprising the same as an active ingredient, which is useful for preventing or treating metabolic disorders, particularly, diabetes, are provided.
Abstract translation: 在肠和肾中存在对钠依赖性葡萄糖共转运体2（SGLT2）具有抑制活性的新型C-芳基葡糖苷化合物或其药学上可接受的盐或前药; 并且提供了包含其作为活性成分的药物组合物，其可用于预防或治疗代谢紊乱，特别是糖尿病。
-
5.发明申请
公开(公告)号：US20130196227A1
公开(公告)日：2013-08-01
申请号：US13571249
申请日：2012-08-09
Applicant: Hyun-Deok LEE , Yong-Chul Park , Mi-Ran Song , Jin-Hyoung Seo , Min-Ju Kim , Na-Leum Yoo , Gyeong-Jae Heo
Inventor： Hyun-Deok LEE , Yong-Chul Park , Mi-Ran Song , Jin-Hyoung Seo , Min-Ju Kim , Na-Leum Yoo , Gyeong-Jae Heo
CPC classification number: H01M4/621 , H01M4/0471 , H01M4/131 , H01M4/1391 , H01M4/505
Abstract: A positive electrode including a current collector and a positive active material layer formed on the current collector, wherein the positive active material layer includes a positive active material, a conductive agent, and the boron-containing inorganic binder having a network structure; a method of manufacturing the same; and a lithium battery including the positive electrode.
Abstract translation: 在集电体上形成集电体和正极活性物质层的正极，所述正极活性物质层包含正极活性物质，导电剂和具有网状结构的含硼无机粘合剂。 其制造方法; 以及包含正极的锂电池。
-
6.发明申请NOVEL ARYLPIPERAZINE-CONTAINING IMIDAZOLE 4-CARBOXAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITION COMPRISING SAME 有权新颖的含有阿维菌素的咪唑烷四羧酰胺衍生物和包含其的药物组合物
公开(公告)号：US20120115881A1
公开(公告)日：2012-05-10
申请号：US13383143
申请日：2010-07-09
Applicant: Jinhwa Lee , Hee Jeong Seo , Suk Youn Kang , Eun-Jung Park , Min Ju Kim , Suk Ho Lee , Jong yup Kim , Jeongmin Kim , Myung Eun Jung , Hyun Jung Kim , Mi-soon Kim , Ho kyun Han , Kwang Woo Ahn , Min Woo Lee , Ki-Nam Lee , Ae Nim Pae , Woo-Kyu Park
Inventor： Jinhwa Lee , Hee Jeong Seo , Suk Youn Kang , Eun-Jung Park , Min Ju Kim , Suk Ho Lee , Jong yup Kim , Jeongmin Kim , Myung Eun Jung , Hyun Jung Kim , Mi-soon Kim , Ho kyun Han , Kwang Woo Ahn , Min Woo Lee , Ki-Nam Lee , Ae Nim Pae , Woo-Kyu Park
IPC: A61K31/497 , A61P25/24 , C07D403/12
CPC classification number: C07D417/14 , A61K31/496 , C07D233/88 , C07D401/12 , C07D403/06 , C07D405/04
Abstract: A novel arylpiperazine-containing imidazole 4-carboxamide derivative or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the same as an active ingredient for preventing or treating a depressive disorder are provided.
Abstract translation: 提供了一种新的含有芳基哌嗪的咪唑-4-甲酰胺衍生物或其药学上可接受的盐，以及包含其作为预防或治疗抑郁障碍的活性成分的药物组合物。
-
公开(公告)号：US08128840B2
公开(公告)日：2012-03-06
申请号：US12320553
申请日：2009-01-29
Applicant: Jay-Hyok Song , Yu-Mi Song , Yoon-Chang Kim , Do-Hyung Park , Yong-Chan You , Gyeong-Jae Heo , Ick-Kyu Choi , Mi-Ran Song , Seon-Young Kwon , Hyun-Deok Lee , Ji-Hyun Kim , Jin-Hyoung Seo , Sun-Hwa Kwon , Ji-Hyun Kim , Min-Ju Kim , Young-Hun Lee , Young-Ki Kim
Inventor： Jay-Hyok Song , Yu-Mi Song , Yoon-Chang Kim , Do-Hyung Park , Yong-Chan You , Gyeong-Jae Heo , Ick-Kyu Choi , Mi-Ran Song , Seon-Young Kwon , Hyun-Deok Lee , Ji-Hyun Kim , Jin-Hyoung Seo , Sun-Hwa Kwon , Ji-Hyun Kim , Min-Ju Kim , Young-Hun Lee , Young-Ki Kim
IPC: C09K11/80
CPC classification number: C09K11/7774 , C09K11/595 , C09K11/643 , C09K11/662 , C09K11/778
Abstract: A phosphor composition for a display device, including a phosphor represented by Formula 1: Y3-x-k-zCekMzM′xAla-yM″yO(1.5a+4.5) (1). In Formula 1, M includes at least one of Tb, Dy, and Eu, M′ includes at least one of Sc, Gd, In, and La, M″ includes at least one of Ga, Sc, and In, and x, y, z, k, and a represent molar ratios and satisfy the relations: 0.0≦x
Abstract translation: 一种显示装置用荧光体组合物，其包括由式1表示的荧光体：Y3-x-k-zCekMzM'xAla-yM“yO（1.5a + 4.5）（1）。 在式1中，M包括Tb，Dy和Eu中的至少一种，M'包括Sc，Gd，In和La中的至少一个，M“包括Ga，Sc和In中的至少一种，x， y，z，k和a表示摩尔比，满足关系：0.0＆nlE; x <3.0,0.0＆nlE; y＆nlE; 7.0,0.0
-
公开(公告)号：US20090206724A1
公开(公告)日：2009-08-20
申请号：US12320548
申请日：2009-01-29
Applicant: Ji-Hyun Kim , Yoon-Chang Kim , Yong-Chan You , Do-Hyung Park , Ick-Kyu Choi , Min-Ju Kim , Gyeong-Jae Heo , Mi-Ran Song , Hyun-Deok Lee , Jay-Hyok Song , Sun-Hwa Kwon , Yu-Mi Song , Jin-Hyoung Seo , Young-Hun Lee , Ji-Hyun Kim , Young-Ki Kim
Inventor： Ji-Hyun Kim , Yoon-Chang Kim , Yong-Chan You , Do-Hyung Park , Ick-Kyu Choi , Min-Ju Kim , Gyeong-Jae Heo , Mi-Ran Song , Hyun-Deok Lee , Jay-Hyok Song , Sun-Hwa Kwon , Yu-Mi Song , Jin-Hyoung Seo , Young-Hun Lee , Ji-Hyun Kim , Young-Ki Kim
CPC classification number: C09K11/778 , C09K11/595 , C09K11/623 , C09K11/646 , C09K11/666 , C09K11/7774
Abstract: A green phosphor, including a first phosphor represented by Formula 1: (Y3-xCex)aAlbOc (1), wherein x, a, b, and c satisfy the relations: 0
Abstract translation: 包括由式1表示的第一荧光体的绿色荧光体：<？in-line-formula description =“In-line formula”end =“lead”→>（Y3-xCex）aAlbOc（1），< -formulae description =“In-line Formulas”end =“tail”？>其中x，a，b和c满足关系：0
-
公开(公告)号：US20090194740A1
公开(公告)日：2009-08-06
申请号：US12320764
申请日：2009-02-04
Applicant: Gyeong-Jae Heo , Mi-Ran Song , Young-Hun Lee , Yoon-Chang Kim , Yong-Chan You , Do-Hyung Park , Hyun-Deok Lee , Seon-Young Kwon , Ji-Hyun Kim , Ick-Kyu Choi , Ji-Hyun Kim , Yu-Mi Song , Jay-Hyok Song , Min-Ju Kim , Sun-Hwa Kwon , Young-Ki Kim
Inventor： Gyeong-Jae Heo , Mi-Ran Song , Young-Hun Lee , Yoon-Chang Kim , Yong-Chan You , Do-Hyung Park , Hyun-Deok Lee , Seon-Young Kwon , Ji-Hyun Kim , Ick-Kyu Choi , Ji-Hyun Kim , Yu-Mi Song , Jay-Hyok Song , Min-Ju Kim , Sun-Hwa Kwon , Young-Ki Kim
CPC classification number: C09K11/7734 , C09K11/595 , C09K11/662 , C09K11/7774 , C09K11/778 , H01J11/12 , H01J11/42
Abstract: A phosphor composition including a first phosphor represented by Formula 1: Ba1−bMg1−aAl10O17:Mna,Eub (1). In Formula 1, a and b satisfy the relations: 0.05≦a≦0.4, and 0.006≦b
Abstract translation: 包含由式1表示的第一荧光体的荧光体组合物：<？in-line-formula description =“In-line formula”end =“lead”→> Ba1-bMg1-aAl10O17：Mna，Eub（1） -line-formula description =“In-line Formulas”end =“tail”？>在公式1中，a和b满足关系：0.05 <= a <= 0.4，而0.006 <= b <0.05。
-
公开(公告)号：US20140088079A1
公开(公告)日：2014-03-27
申请号：US14122836
申请日：2012-06-01
Applicant: Soongyu Choi , Kwang Seop Song , Suk Ho Lee , Min Ju Kim , Hee Jeong Seo , Eun-Jung Park , Younggyu Kong , So Ok Park , Hyunku Kang , Myung Eun Jung , Kinam Lee , Hyun Jung Kim , Jun Sung Lee , Min Woo Lee , Mi-Soon KIM , Dong Ho Hong , Misuk Kang
Inventor： Soongyu Choi , Kwang Seop Song , Suk Ho Lee , Min Ju Kim , Hee Jeong Seo , Eun-Jung Park , Younggyu Kong , So Ok Park , Hyunku Kang , Myung Eun Jung , Kinam Lee , Hyun Jung Kim , Jun Sung Lee , Min Woo Lee , Mi-Soon KIM , Dong Ho Hong , Misuk Kang
IPC: C07D309/10 , C07D405/10 , C07D413/04 , C07D409/10 , C07D413/10 , C07D405/14 , C07D407/04 , C07D407/10
CPC classification number: C07D309/10 , C07D405/10 , C07D405/14 , C07D407/04 , C07D407/10 , C07D407/14 , C07D409/04 , C07D409/10 , C07D409/14 , C07D411/10 , C07D413/04 , C07D413/10 , C07D413/12 , C07D413/14
Abstract: The present invention relates to a compound with a diphenylmethane moiety having an inhibitory activity against sodium-dependent glucose cotransporter 2 (SGLT2) being present in the intestine and kidney, and a pharmaceutical composition comprising the same as an active ingredient, which is useful for preventing or treating metabolic disorders, particularly diabetes. The present invention also provides a method for preparing the compound, and a method for preventing or treating metabolic disorders, particularly diabetes, by using the compound.
Abstract translation: 本发明涉及具有对存在于肠和肾中的钠依赖性葡萄糖协同转运蛋白2（SGLT2）具有抑制活性的二苯基甲烷部分的化合物和包含其作为活性成分的药物组合物，其可用于预防 或治疗代谢紊乱，特别是糖尿病。 本发明还提供了一种制备该化合物的方法，以及通过使用该化合物来预防或治疗代谢紊乱，特别是糖尿病的方法。
